Related Experiment Videos

Antibody responses in patients with farmer's lung disease to antigens from Micropolyspora faeni

The Journal of Hygiene
|February 1, 1974
PubMed

Insights

Farmer's lung disease involves immune responses to Micropolyspora faeni antigens. Glycoprotein antigens trigger antibodies only in patients, suggesting a specific diagnostic marker for farmer's lung.

Area of Science:

  • Immunology
  • Microbiology
  • Pulmonary Medicine

Background:

  • Farmer's lung disease is a hypersensitivity pneumonitis.
  • It is caused by exposure to thermophilic actinomycetes, such as Micropolyspora faeni.
  • Identifying specific antigens and immune responses is crucial for diagnosis and understanding pathogenesis.

Purpose of the Study:

  • To isolate and characterize antigens from Micropolyspora faeni.
  • To investigate the antibody responses to these antigens in farmer's lung disease patients and healthy farmers.
  • To elucidate the immunological mechanisms involved in farmer's lung disease.

Main Methods:

  • Extraction of glycoprotein and protein antigens from Micropolyspora faeni mycelium using phenol or trichloroacetic acid.
  • Purification and characterization of antigens using immunoelectrophoresis.
  • Analysis of patient and farmer sera for antibodies using precipitins and latex agglutination tests.
  • Fractionation of immunoglobulins (IgG, IgA, IgM).

Main Results:

  • Three purified glycoprotein antigens (a, b, c) and protein antigens were extracted.
  • Antibodies to glycoprotein antigens were specific to farmer's lung disease patients.
  • Antibodies to protein antigens were found in both patients and asymptomatic farmers.
  • Precipitins to antigen 'a' were present in all farmer's lung disease cases.
  • Precipitins were primarily IgG, while latex-agglutinating antibodies included IgG, IgA, and IgM.

Conclusions:

  • Glycoprotein antigen 'a' is a potential diagnostic marker for farmer's lung disease.
  • Farmer's lung disease may involve a cytotoxic type II hypersensitivity reaction.
  • The reaction involves glycoproteins on cell surfaces interacting with patient immunoglobulins and complement, leading to tissue damage.

Related Concept Videos